Scientific materials
Below we present selected scientific materials, articles and research publications related to our products. They focus on cannabinoid and essential oil applications in cosmetics, medicine and veterinary and describe their anti-inflammatory, analgesic and antiviral properties. We encourage you to conduct your own research, especially in case of deeper interest in specific cannabinoid and essential oil related issues.
Cosmetics and dermatology
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/
Cannabinoids in dermatology: a scoping review (1)
https://www.ncbi.nlm.nih.gov/pubmed/30142706
Cannabinoids in dermatology: a scoping review (2)
https://escholarship.org/uc/item/7pn8c0sb
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
The Therapeutic Potential of Cannabinoids in Dermatology
https://www.ncbi.nlm.nih.gov/pubmed/30517778
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429381/
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
Medicine
Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
https://pubmed.ncbi.nlm.nih.gov/32714224/
CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action
https://pubmed.ncbi.nlm.nih.gov/33964342/
The antimicrobial potential of cannabidiol
https://www.nature.com/articles/s42003-020-01530-y
Cannabinoids Block Cellular Entry of SARS-CoV-2 Virus and the Emerging Variants
https://pubmed.ncbi.nlm.nih.gov/35007072/
Cannabidiol Inhibits SARS-CoV-2 Virus Replication and Promotes the Host Innate Immune Response
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987002/
Cannabinoid Acids: medical benefits of THCa and CBDa
https://www.kalapa-clinic.com/en/cannabinoid-acids-thca-and-cbda/
Veterinary
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
https://pubmed.ncbi.nlm.nih.gov/31635105/
Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy
https://pubmed.ncbi.nlm.nih.gov/31067185/
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
https://pubmed.ncbi.nlm.nih.gov/32345916/
Feline cognitive dysfunction as a model for Alzheimer's disease in the research of CBD as a potential treatment-a narrative review
https://pubmed.ncbi.nlm.nih.gov/33526138/
Safety and tolerability of escalating cannabinoid doses in healthy cats